Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Indian pharma firm Zydus group's formulation manufacturing facility established in Baddi, Himachal Pradesh, India.
Subscribe to our email newsletter
Zydus’ Baddi manufacturing plant engaged in manufacturing oral solid dosage forms of drugs include hard gelatin capsules and tablets.
Zydus Cadila chairman and managing director Pankaj Patel said the FDA approval for the Baddi plant enables them to open up an additional resource to cater to the growing needs of their US business.
Zydus is a discoverer, developer, manufacturer and marketer of a range of healthcare products.